Lombard Odier Asset Management (USA) Corp - 31 Dec 2024 SCHEDULE 13G/A Report for Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares") (SLN)

Filing Manager: Lombard Odier Asset Management (USA) Corp
Reporting Manager: Lombard Odier Asset Management (USA) Corp
Security: Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares")
Symbol: SLN
Shares outstanding: 140,968,776 shares
Disclosed Ownership: 10,713,627 shares
Ownership: 7.6%
Form type: SCHEDULE 13G/A
Filing time: 11 Feb 2025, 18:41:36 UTC
Date of event: 31 Dec 2024
Next filing: 09 Feb 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lombard Odier Asset Management (USA) Corp	7.6%	10,713,627	0	10,713,627	/s/ Elyse Strauss	Authorized Signatory